MIRAVANT MEDICAL TECHNOLOGIES
4, 2000-11-03
PHARMACEUTICAL PREPARATIONS
Previous: MIRAVANT MEDICAL TECHNOLOGIES, 4, 2000-11-03
Next: BUFFALO USA GLOBAL FUND INC, NSAR-A, 2000-11-03



UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16.
    Form 4 or Form 5 obligations may continue.

1. Name and Address of Reporting Person(s)
   Larry S. Barels
   336 Bollay Drive
   Santa Barbara, CA  93117

2. Issuer Name and Ticker or Trading Symbol
   Miravant Medical Technologies (MRVT)

3. I.R.S. Identification Number of Reporting Person, if an entity (Voluntary)

4. Statement for Month/Year
   10/00

5. If Amendment, Date of Original (Month/Year)

6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   [X] Director                   [ ] 10% Owner
   [ ] Officer (give title below) [ ] Other (specify below)

7. Individual or Joint/Group Filing (Check Applicable Line)
   [X] Form filed by One Reporting Person
   [ ] Form filed by More than One Reporting Person

<TABLE>
<CAPTION>
Table I   Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
------------------------------------------------------------------------------------------------------------------------------------
1)Title of Security                           2)Trans-    3.Trans- 4.Securities Acquired(A)      5)Amount of    6)  7)Nature of
                                              action      action   or Disposed of (D)            Securities         Indirect
                                              Date        Code                   A               Beneficially   D   Beneficial
                                              (Month/                            or              Owned at       or  Ownership
                                              Day/Year)   Code V   Amount        D  Price        End of Month   I
------------------------------------------------------------------------------------------------------------------------------------
<S>                                           <C>         <C>      <C>           <C><C>          <C>            <C><C>
Common Stock                                  10/23/00    P        35,000        A  $14.7232                    D  Direct
Common Stock                                  10/23/00    M        3,125         A  $12.5000     129,875        D  Direct
Common Stock                                                                                     3,000          I  by Daughter
Common Stock                                                                                     2,500          I  by Spouse

<CAPTION>
Table II (PART 1)  Derivative Securities Acquired, Disposed of, or Beneficially Owned  (Columns 1 through 6)
------------------------------------------------------------------------------------------------------------------------------------
1)Title of Derivative          2)Conversion    3)Trans-       4)Trans-  5)Number of Derivative            6)Date Exercisable and
Security                       or Exercise     action         action    Securities Acquired (A)           Expiration Date
                               Price of        Date           Code      or Disposed of (D)
                               Derivative
                               Security                       Code  V   A                D                Exercisable  Expiration
------------------------------------------------------------------------------------------------------------------------------------
<S>                            <C>             <C>            <C>       <C>              <C>              <C>          <C>
Non-Qualified Stock Option     $12.5000        10/23/00       M                          3,125            02/18/99 (1) 11/18/08
(right to buy)
Non-Qualified Stock Option     $21.3125        10/01/00 (2)   A         7,500                             10/01/00     10/01/10
(right to buy)

<CAPTION>
Table II (PART 2)  Derivative Securities Acquired, Disposed of, or Beneficially Owned  (Columns 1,3 and 7 through 11)
------------------------------------------------------------------------------------------------------------------------------------
1)Title of Derivative          3)Trans-  7)Title and Amount                           8)Price     9)Number of   10) 11)Nature of
Security                       action    of Underlying                                of Deri-    Derivative        Indirect
                               Date      Securities                                   vative      Securities    D   Beneficial
                                                                        Amount or     Security    Beneficially  or  Ownership
                                                                        Number of                 Owned at      I
                  -                      Title                          Shares                    End of Month
------------------------------------------------------------------------------------------------------------------------------------
<S>                            <C>       <C>                            <C>           <C>         <C>           <C> <C>
Non-Qualified Stock Option     10/23/00  Common Stock                   3,125                     28,125        D   Direct
(right to buy)
Non-Qualified Stock Option     10/01/00  Common Stock                   7,500         $21.3125    7,500         D   Direct
(right to buy)                 (2)

<FN>
Explanation of Responses:

(1)
Options vest ratably and quarterly over a four year period commencing on date indicated when the first 6.25% vests and becomes
exercisable.
(2)
Automatic grant to outside director in consideration of service as board member.

</FN>
</TABLE>
SIGNATURE OF REPORTING PERSON

/s/ Larry S. Barels
---------------
    Larry S. Barels

DATE  11/1/00


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission